Altimmune ALT Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's accrued expenses and other liabilities?
- Altimmune (ALT) reported accrued expenses and other liabilities of -$2.49M in Q1 2026.
- How has Altimmune's accrued expenses and other liabilities changed year-over-year?
- Altimmune's accrued expenses and other liabilities decreased by 46.7% year-over-year, from -$1.7M to -$2.49M.